Martin N, Sattentau Q. Cell-to-cell HIV-1 spread and its implications for immune evasion. Curr Opin HIV AIDS. 2009;4(2):143–9.
Article
PubMed
Google Scholar
Alexaki A, Liu Y, Wigdahl B. Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res. 2008;6(5):388–400.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ford ES, Puronen CE, Sereti I. Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm. Curr Opin HIV AIDS. 2009;4(3):206–14.
Article
PubMed
PubMed Central
Google Scholar
Brooks JT, et al. HIV-associated opportunistic infections–going, going, but not gone: the continued need for prevention and treatment guidelines. Clin Infect Dis. 2009;48(5):609–11.
Article
PubMed
Google Scholar
Palella FJ Jr, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853–60.
Article
PubMed
Google Scholar
Raboud JM, et al. Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy. AIDS. 1998;12(13):1619–24.
Article
CAS
PubMed
Google Scholar
Lange CG, Lederman MM. Immune reconstitution with antiretroviral therapies in chronic HIV-1 infection. J Antimicrob Chemother. 2003;51(1):1–4.
Article
CAS
PubMed
Google Scholar
Kaufmann GR, et al. The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy. AIDS. 2002;16(3):359–67.
Article
CAS
PubMed
Google Scholar
Autran B, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 1997;277(5322):112–6.
Article
CAS
PubMed
Google Scholar
Mocroft A, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet. 1998;352(9142):1725–30.
Article
CAS
PubMed
Google Scholar
Vittinghoff E, et al. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. J Infect Dis. 1999;179(3):717–20.
Article
CAS
PubMed
Google Scholar
Egger M, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360(9327):119–29.
Article
PubMed
Google Scholar
Garcia F, et al. Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count. J Acquir Immune Defic Syndr. 2004;36(2):702–13.
Article
PubMed
Google Scholar
Mocroft A, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362(9377):22–9.
Article
CAS
PubMed
Google Scholar
Kaufmann GR, et al. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med. 2003;163(18):2187–95.
Article
PubMed
Google Scholar
Hunt PW, et al. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS. 2003;17(13):1907–15.
Article
PubMed
Google Scholar
Panel on Antiretroviral Guidelines for Adults and Adolescents. Washington, D.D.o.H.a.H.S., Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. 2008.
Lau B, Gange SJ, Moore RD. Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3. J Acquir Immune Defic Syndr. 2007;44(2):179–87.
Article
PubMed
Google Scholar
Marin B, et al. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS. 2009;23(13):1743–53.
Article
PubMed
PubMed Central
Google Scholar
Lewden C, et al. HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr. 2007;46(1):72–7.
PubMed
Google Scholar
Obel N, et al. Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort study. PLoS ONE. 2011;6(7):e22698.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rodger AJ, et al. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS. 2013;27(6):973–9.
Article
CAS
PubMed
Google Scholar
Lewden C, et al. All-cause mortality in treated HIV-infected adults with CD4>/=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol. 2012;41(2):433–45.
Article
PubMed
Google Scholar
Le Moing V, et al. Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently < 500 copies/mL during treatment with antiretroviral drugs. HIV Med. 2007;8(3):156–63.
Article
PubMed
Google Scholar
Luz PM, et al. Long-term CD4+ cell count in response to combination antiretroviral therapy. PLoS ONE. 2014;9(4):e93039.
Article
PubMed
PubMed Central
Google Scholar
Kelley CF, et al. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis. 2009;48(6):787–94.
Article
PubMed
PubMed Central
Google Scholar
Rajasuriar R, et al. Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database. PLoS ONE. 2011;6(6):e20713.
Article
CAS
PubMed
PubMed Central
Google Scholar
Baker JV, et al. CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS. 2008;22(7):841–8.
Article
PubMed
PubMed Central
Google Scholar
Baker JV, et al. Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases. J Acquir Immune Defic Syndr. 2008;48(5):541–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lichtenstein KA, et al. Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. Clin Infect Dis. 2010;51(4):435–47.
Article
CAS
PubMed
Google Scholar
Mzileni MO, Longo-Mbenza B, Chephe TJ. Mortality and causes of death in HIV-positive patients receiving antiretroviral therapy at Tshepang Clinic in Doctor George Mukhari Hospital. Pol Arch Med Wewn. 2008;118(10):548–54.
PubMed
Google Scholar
Cuzin L, et al. Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged > 50 years. Clin Infect Dis. 2007;45(5):654–7.
Article
PubMed
Google Scholar
Onen NF, et al. Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome. HIV Med. 2009;10(7):439–46.
Article
CAS
PubMed
Google Scholar
Misgena DK. The pattern of immunologic and virologic responses to Highly Active Antiretroviral Treatment (HAART): does success bring further challenges? Ethiop J Health Dev. 2011;25(1):61–70.
Google Scholar
Nanzigu S, et al. Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naive Ugandans. HIV AIDS (Auckl). 2013;5:309–19.
Google Scholar
Kaufmann GR, et al. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to < 500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clin Infect Dis. 2005;41(3):361–72.
Article
PubMed
Google Scholar
Gandhi RT, et al. Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. J Acquir Immune Defic Syndr. 2006;42(4):426–34.
Article
CAS
PubMed
Google Scholar
Maini MK, et al. Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. Genitourin Med. 1996;72(1):27–31.
CAS
PubMed
PubMed Central
Google Scholar
Viard JP, et al. Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis. 2001;183(8):1290–4.
Article
CAS
PubMed
Google Scholar
Khoury G, et al. The role of naive T-cells in HIV-1 pathogenesis: an emerging key player. Clin Immunol. 2011;141(3):253–67.
Article
CAS
PubMed
Google Scholar
Gaardbo JC, et al. Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions. Clin Dev Immunol. 2012;2012:670957.
Article
PubMed
PubMed Central
Google Scholar
Althoff KN, et al. Virologic and immunologic response to HAART, by age and regimen class. AIDS. 2010;24(16):2469–79.
Article
PubMed
PubMed Central
Google Scholar
Moore RD, Keruly JC. CD4 + cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis. 2007;44(3):441–6.
Article
PubMed
Google Scholar
Yeni PG, et al. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA. 2004;292(2):251–65.
Article
CAS
PubMed
Google Scholar